George Washington University
- Advisory Board: Eli Lilly and Company
- Consultant: Otsuka America Pharmaceuticals, Inc.
- Honorarium for participation in this meeting: American Academy of Child & Adolescent Psychiatry
- Research Support: Bristol-Myers Squibb; Forest Laboratories, Inc.; GlaxoSmithKline; Johnson & Johnson; Merck/Schering-Plough; National Institute of Child Health and Human Development; Otsuka America Pharmaceuticals, Inc.; Supernus Pharmaceuticals, Inc.
- Royalties: Epocrates
- Speakers Bureau: Bristol-Myers Squibb; Eli Lilly and Company
- Stock or Equity: Eli Lilly and Company; GlaxoSmithKline; Johnson & Johnson; Pfizer Inc.
- co-chair of Data Safety Monitoring Board: Otsuka America Pharmaceuticals, Inc.
- stock holdings less than $5000 in ira: Eli Lilly and Company; GlaxoSmithKline; Johnson & Johnson
- stock less than $5000 in IRA: Pfizer Inc.
- they are combined sponsor of a set of studies so listed as one entity: Merck/Schering-Plough